Karen Barrett

2.0k total citations
43 papers, 1.5k citations indexed

About

Karen Barrett is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Karen Barrett has authored 43 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 21 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Karen Barrett's work include Inflammatory Bowel Disease (22 papers), Microscopic Colitis (18 papers) and Liver Diseases and Immunity (7 papers). Karen Barrett is often cited by papers focused on Inflammatory Bowel Disease (22 papers), Microscopic Colitis (18 papers) and Liver Diseases and Immunity (7 papers). Karen Barrett collaborates with scholars based in United Kingdom, United States and Australia. Karen Barrett's co-authors include James W. Kronstad, Simon Alaluf, Sarah Gold, Gillian Duncan, Alan Heath, Margaret Blount, Derek Atkins, William J. Sandborn, Gary R. Lichtenstein and Kirstin Lees and has published in prestigious journals such as Genes & Development, The EMBO Journal and Gastroenterology.

In The Last Decade

Karen Barrett

37 papers receiving 1.4k citations

Peers

Karen Barrett

DERMA

EPIDE

GENET

Faith M. Strickland United States

John Su Australia

Mary Gail Mercurio United States

J.‐P. Ortonne France

Rohan Lourie Australia

Yujie Zhang China

Sidharth Sonthalia India

Electra Nicolaidou Greece

Andrzej Kaszuba Poland

Chang Ook Park South Korea

Faith M. Strickland United States

Karen Barrett

350 ×0.9

DERMA

146 ×0.4

610 ×2.0

179 ×0.6

EPIDE

182 ×0.6

GENET

Citations per year, relative to Karen Barrett Karen Barrett (= 1×) peers Faith M. Strickland

Countries citing papers authored by Karen Barrett

Since Specialization

Citations

This map shows the geographic impact of Karen Barrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Barrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Barrett more than expected).

Fields of papers citing papers by Karen Barrett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Barrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Barrett. The network helps show where Karen Barrett may publish in the future.

Co-authorship network of co-authors of Karen Barrett

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Barrett. A scholar is included among the top collaborators of Karen Barrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Barrett. Karen Barrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pararasa, Chathyan, David J. Messenger, Karen Barrett, et al.. (2022). Lower polyunsaturated fatty acid levels and FADS2 expression in adult compared to neonatal keratinocytes are associated with FADS2 promotor hypermethylation. Biochemical and Biophysical Research Communications. 601. 9–15. 1 indexed citations

Kim, Jee Whang, Karen Barrett, Yoon K. Loke, & Andrew M. Wilson. (2020). The effect of statin therapy on disease-related outcomes in idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Respiratory Medicine and Research. 80. 100792–100792. 9 indexed citations

Stevens, Toer, K Gecse, Karen Barrett, et al.. (2019). P161 Faecal calprotectin identifies microscopic inflammation in ulcerative colitis patients with complete endoscopic healing: a post-hoc analysis of the MOMENTUM trial. Journal of Crohn s and Colitis. 13(Supplement_1). S169–S169.

Pierce, David M., Mary Corcoran, Patrick Martin, et al.. (2014). Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials. Drug Design Development and Therapy. 8. 529–529. 9 indexed citations

Raskin, Jeffrey B., Michael A. Kamm, M. Mazen Jamal, et al.. (2014). Mesalamine Did Not Prevent Recurrent Diverticulitis in Phase 3 Controlled Trials. Gastroenterology. 147(4). 793–802. 65 indexed citations

D’Haens, Geert, et al.. (2012). Once-Daily MMX® Mesalamine for Endoscopic Maintenance of Remission of Ulcerative Colitis. The American Journal of Gastroenterology. 107(7). 1064–1077. 37 indexed citations

Kane, Sunanda V., Seymour Katz, Mazen M. Jamal, et al.. (2011). Strategies in maintenance for patients receiving long-term therapy (SIMPLE): A study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis*. Inflammatory Bowel Diseases. 18(6). 1026–1033. 26 indexed citations

Kane, Sunanda V., et al.. (2010). W1328 MMX® Mesalamine 2.4g/Day Maintains Clinical Remission in Patients With Mild-to-Moderate Ulcerative Colitis, Irrespective of Prior Treatment. Gastroenterology. 138(5). S–700. 1 indexed citations

Lichtenstein, Gary R., et al.. (2009). Induction of mucosal healing in mild-to-moderate ulcerative colitis in patients treated with MMX mesalamine: established versus newly diagnosed disease. Inflammatory Bowel Diseases. 15. S35–S35.

10.

Kamm, Michael A., Gary R. Lichtenstein, William J. Sandborn, et al.. (2008). Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis. Inflammatory Bowel Diseases. 15(1). 1–8. 68 indexed citations

11.

Kamm, M A, Gary R. Lichtenstein, William J. Sandborn, et al.. (2008). Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis. Gut. 57(7). 893–902. 135 indexed citations

12.

Lichtenstein, Gary R., MA Kamm, W. Sandborn, et al.. (2007). MMX mesalamine induces remission of mild-to-moderate ulcerative colitis in patients who have changed directly from other oral 5-ASA therapies and in those who have not previously received or who have discontinued 5-ASA. Inflammatory Bowel Diseases. 13(supplement). 667–667.

13.

Sandborn, William J., Robyn G. Karlstadt, Karen Barrett, & Raymond E. Joseph. (2007). Time to Initial Symptom Resolution with MMX™ Mesalamine Therapy for Active, Mild-to-Moderate Ulcerative Colitis. The American Journal of Gastroenterology. 102. S462–S463. 1 indexed citations

14.

Liu, David, Riad Salem, James T. Bui, et al.. (2005). Angiographic Considerations in Patients Undergoing Liver-directed Therapy. Journal of Vascular and Interventional Radiology. 16(7). 911–935. 163 indexed citations

15.

Alaluf, Simon, et al.. (2003). Ethnic Variation in Tyrosinase and TYRP1 Expression in Photoexposed and Photoprotected Human Skin. Pigment Cell Research. 16(1). 35–42. 35 indexed citations

16.

Alaluf, Simon, et al.. (2002). Ethnic Variation in Melanin Content and Composition in Photoexposed and Photoprotected Human Skin. Pigment Cell Research. 15(2). 112–118. 166 indexed citations

17.

Alaluf, Simon, et al.. (2002). The Impact of Epidermal Melanin on Objective Measurements of Human Skin Colour. Pigment Cell Research. 15(2). 119–126. 120 indexed citations

18.

Alaluf, Simon, Alan Heath, Derek Atkins, et al.. (2001). Variation in Melanin Content and Composition in Type V and VI Photoexposed and Photoprotected Human Skin: The Dominant Role of DHI. Pigment Cell Research. 14(5). 337–347. 63 indexed citations

19.

Bellamy, K., et al.. (1998). Detection of viruses and body fluids which may contain viruses in the domestic environment. Epidemiology and Infection. 121(3). 673–680. 23 indexed citations

20.

Gold, Sarah, Gillian Duncan, Karen Barrett, & James W. Kronstad. (1994). cAMP regulates morphogenesis in the fungal pathogen Ustilago maydis.. Genes & Development. 8(23). 2805–2816. 257 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact